Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$343K Hold
948
0.16% 89
2026
Q1
$334K Hold
948
0.17% 85
2025
Q4
$310K Sell
948
-75
-7% -$23.8K 0.16% 85
2025
Q3
$289K Hold
1,023
0.15% 90
2025
Q2
$286K Buy
1,023
+65
+7% +$18.4K 0.17% 78
2025
Q1
$298K Buy
958
+50
+6% +$14.8K 0.19% 74
2024
Q4
$237K Sell
908
-15
-2% -$4.45K 0.14% 79
2024
Q3
$297K Buy
923
+160
+21% +$52.3K 0.17% 74
2024
Q2
$238K Hold
763
0.15% 81
2024
Q1
$217K Sell
763
-48
-6% -$14K 0.14% 81
2023
Q4
$255K Buy
811
+50
+7% +$13.6K 0.17% 76
2023
Q3
$205K Sell
761
-200
-21% -$49.9K 0.14% 79
2023
Q2
$213K Buy
+961
New +$223K 0.14% 80
2020
Q2
$275K Buy
+1,166
New +$266K 0.23% 72

Other funds holding AMGN

Cape Ann Savings Bank's AMGN Position: Q2 2026 in Review

Cape Ann Savings Bank held its Amgen (AMGN) position steady in Q2 2026 at 948 shares worth $343K. The position accounts for 0.16% of the portfolio, ranked #89.

Cape Ann Savings Bank first reported a position in AMGN in Q2 2020 and has held it in 14 quarters since. 1,943 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cape Ann Savings Bank held 948 shares of Amgen worth $343K as of Q2 2026.
  • Cape Ann Savings Bank left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.16% of Cape Ann Savings Bank's portfolio in Q2 2026, its #89 holding.
  • Cape Ann Savings Bank first reported a position in Amgen in Q2 2020 and has held it in 14 quarters since.
  • 1,943 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cape Ann Savings Bank's 13F filing for Q2 2026, filed 4 Aug 2026.